Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse
Clinical trial NCT04475731 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04475731
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-04
- Primary completion
- 2024-11-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.